Results 251 to 260 of about 83,224 (354)

144 Polypharmacy and Anticholinergic Burden in Older People in Brunei Darussalam [PDF]

, 2019
Su Ying Yeo, Sanny Zi Lung Choo, Nadzirah Rosli, Eng Chong Koh, Shyh Poh Teo   +4 more
openalex   +1 more source

Polypharmacy in HIV: Rethinking what counts and why it matters

HIV Medicine, Volume 27, Issue 2, Page 186-199, February 2026.
Abstract Polypharmacy, the concurrent use of multiple medications, presents a growing challenge in HIV care as people living with HIV age and experience earlier onset of age‐related co‐morbidities. However, how polypharmacy is defined and assessed in HIV research remains inconsistent.
Luxsena Sukumaran, Alan Winston, Catia Marzolini, Saye Khoo, Marta Boffito, Nadia Naous, Caroline A. Sabin   +6 more
wiley   +1 more source

Anticholinergic and sedative medications use among community dwelling older adults: risk for polypharmacy and poor physical function. [PDF]

BMC Geriatr
Selcuk A, Atmis V, Sen S, Gemci E, Yurumez B, Yalcin A, Bozkir A, Aras S, Varli M.   +8 more
europepmc   +1 more source

Clinical and economic outcomes for patients initiating fluticasone propionate/salmeterol combination therapy (250/50 mcg) versus anticholinergics in a comorbid COPD/depression population

, 2012
Dalal AA, Manan Shah, D amp Souza AO, Sameer Chaudhari, Glenn Crater   +4 more
openalex   +1 more source

Individual and Institutional Factors Associated With Urinary Incontinence Among Nursing Home Residents: A Multilevel Analysis

Journal of Advanced Nursing, Volume 82, Issue 2, Page 1326-1340, February 2026.
ABSTRACT Aims (1) To analyse individual and institutional‐level factors associated with urinary incontinence in older adults living in nursing homes; (2) to estimate the prevalence of urinary, faecal and double incontinence in nursing home residents. Design Cross‐sectional study. Methods Residents aged 65+ living in 22 nursing homes in Catalonia (Spain)
Javier Jerez‐Roig, Nayara Priscila Dantas de Oliveira, Pau Moreno‐Martin, Júlia Casacuberta‐Roca, Dyego Leandro Bezerra de Souza, Ester Goutan‐Roura, Laura Coll‐Planas, Adrian Wagg, William Gibson, Xavier Gómez‐Batiste   +9 more
wiley   +1 more source

Polypharmacy, anticholinergic burden and oral microbiome among U.S. middle-aged and older adults: a representative national survey. [PDF]

J Oral Microbiol
Wei K, Yang Y, Chen C, Yang Y, Hu K, Chen Q.   +5 more
europepmc   +1 more source

Patient Agitation in the Intensive Care Unit: A Concept Analysis

Journal of Advanced Nursing, Volume 82, Issue 2, Page 1737-1749, February 2026.
ABSTRACT Aim Exploring the concept of patient agitation in the intensive care unit. Background Patient agitation in the intensive care unit is of widespread concern and linked to negative outcomes for patients, staff, and family members. There is currently no consensus on what constitutes agitation in the intensive care context, hindering effective and
Anne Mette N. Adams, Diane Chamberlain, Charlotte Brun Thorup, Matthew J. Maiden, Cherie Waite, Hila Ariela Dafny, Kay Bruce, Tiffany Conroy   +7 more
wiley   +1 more source

A Case of Belladonna Poisoning With Late-Onset Reappearance of Anticholinergic Toxicity. [PDF]

Clin Case Rep
Hayashi T, Hirayama I, Nonaka M, Naraba H, Yano T, Ishii M, Kaizaki-Mitsumoto A, Numazawa S, Tominaga Y, Kamijo Y.   +9 more
europepmc   +1 more source

Effect of moderate altitude and nocturnal oxygen therapy on cerebrovascular function in patients with COPD: A randomized, crossover trial at 2048 m

Experimental Physiology, Volume 111, Issue 2, Page 527-538, 1 February 2026.
Abstract We investigated whether nocturnal oxygen therapy improves next‐day cerebrovascular function in lowlanders with chronic obstructive pulmonary disease (COPD) staying at moderate altitude. This randomized, placebo‐controlled single‐blind crossover trial was performed in moderate‐to‐severe COPD patients [forced expiratory volume in 1 s (FEV1 ...
Dominic Gilliand, Tsogyal D. Latshang, Sayaka S. Aeschbacher, Fabienne Huber, Deborah Flueck, Mona Lichtblau, Stefanie Ulrich, Elisabeth D. Hasler, Philipp M. Scheiwiller, Julian Müller, Silvia Ulrich, Konrad E. Bloch, Michael Furian   +12 more
wiley   +1 more source

Comparative Real-World Safety Profiles of Six Selective Serotonin Reuptake Inhibitors: A Global Pharmacovigilance Analysis. [PDF]

Cureus
Chan ACY.
europepmc   +1 more source